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Abstract Transcription-coupled nucleotide excision repair
(TC-NER) specifically removes transcription-blocking lesions
from our genome. Defects in this pathway are associated with
two human disorders: Cockayne syndrome (CS) and UV-
sensitive syndrome (UVSS). Despite a similar cellular defect
in the UV DNA damage response, patients with these syn-
dromes exhibit strikingly distinct symptoms; CS patients dis-
play severe developmental, neurological, and premature aging
features, whereas the phenotype of UVSS patients is mostly
restricted to UV hypersensitivity. The exact molecular mecha-
nism behind these clinical differences is still unknown; how-
ever, they might be explained by additional functions of CS
proteins beyond TC-NER. A short overview of the current
hypotheses addressing possible molecular mechanisms and
the proteins involved are presented in this review. In addition,
we will focus on two new players involved in TC-NER which
were recently identified: UV-stimulated scaffold protein A
(UVSSA) and ubiquitin-specific protease 7 (USP7). UVSSA
has been found to be the causative gene for UVSS and, together
with USP7, is implicated in regulating TC-NER activity. We
will discuss the function of UVSSA and USP7 and how the
discovery of these proteins contributes to a better understand-
ing of the molecular mechanisms underlying the clinical dif-
ferences between UVSS and the more severe CS.
Introduction
Alterations in the DNA structure that hinder the progression
of RNA polymerases during transcription are highly toxic for
the cell and, if not properly resolved, can lead to cellular
apoptosis or senescence (Ljungman and Zhang 1996; Ljungman
and Lane 2004). Helix-distorting lesions located in the tran-
scribed strand of active genes initiate the transcription-coupled
nucleotide excision repair (TC-NER) pathway to resolve the
transcription-blocking DNA damage (Hanawalt and Spivak
2008). Lesion stalled elongating RNA polymerase II (RNA Pol
II) triggers the recruitment of several TC-NER-specific factors to
form a functional TC-NER complex, including the Cockayne
syndrome A and B (CSA, CSB) proteins (Fousteri et al. 2006)
(Fig. 1a).
Cockayne syndrome versus UV-sensitive syndrome
In humans, defective TC-NER is associated with two autoso-
mal recessive DNA repair deficiency disorders: Cockayne syn-
drome (CS) and UV-sensitive syndrome (UVsS) (Nance and
Berry 1992; Spivak 2005). Although patient-derived cells are
equally deficient in UV-induced TC-NER in vitro, the patients
exhibit strikingly distinct clinical symptoms: CS individuals
display severe developmental, neurological, and premature ag-
ing features, whereas UVSS patients express much milder
features, mostly restricted to UV hypersensitivity. CS is caused
bymutations in two genes indispensable for TC-NER,CSA and
CSB. UVsS comprises three complementation groups, which
are defined by specific mutations in CSA, CSB, and in the
recently identified gene encoding for UV-stimulated scaffold
protein A (UVSSA) (Table 1). Intriguingly, neither the site nor
the nature of the mutations in CSA or CSB seems to correlate
with the clinical differences observed among patients with CS
and UVSS (Nance and Berry 1992; Laugel et al. 2010). Thus,
an important question remains: how do molecular defects with-
in the same TC-NER pathway and even different mutations
within the same genes lead to such diverse pathologies?
Several models are proposed that try to explain the underlying
molecular reason for the wide variety in TC-NER-deficient
phenotype (Sarasin 2012; Cleaver 2012). Most of these
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hypotheses are based on additional functions of the CS proteins
outside of their role in TC-NER while assuming UVSSA is not
implicated in these processes, hence explaining the milder phe-
notype in UVSS (Spivak and Hanawalt 2006) (Fig. 2).
One of these models, the transcription defect model, is mainly
based on data obtained for the CSB protein. CSB is a member of
the SNF2/SWI2 family of DNA-dependent ATPases (Troelstra
et al. 1990) and is suggested to have chromatin remodeling
abilities, possibly through recruitment of the p300 histone
acetyltransferase (Citterio et al. 2000; Newman et al. 2006;
Frontini and Proietti-De-Santis 2009). CSB transiently interacts
with elongating RNA Pol II and stimulates transcription (Balajee
et al. 1997; Dianov et al. 1997; Selby and Sancar 1997; Tantin
et al. 1997; vanGool et al. 1997; van denBoom et al. 2004). This
suggests that when CSB is absent or mutated, transcription
would be affected even in the absence of DNA damage. There
is a growing list of human diseases which are associated with
defects in transcription, and many of these diseases are charac-
terized by congenital defects (Villard 2004), as also observed in
CS patients. This suggests that the severe developmental and
premature aging features of CS could partially be caused by a
defect in transcription, while the sun sensitivity in these patients
is most likely caused by the DNA repair deficiency of the TC-
NER pathway.
Another hypothesis involves a role of the CS proteins in
repairing endogenous DNA damage from reactive oxygen
species (ROS), which is usually repaired by the base excision
repair (BER) machinery (Hegde et al. 2008). Both human and
mouse cell lines deficient in the CS proteins indeed display
enhanced sensitivity to agents that produce oxidative DNA
damage (Dianov et al. 1999; Tuo et al. 2003; de Waard et al.
2004; Gorgels et al. 2007; D’Errico et al. 2007; Stevnsner et al.
2008). Furthermore, Menoni et al. (2012) recently showed
recruitment of CSB to local oxidative DNA lesions in living
cells without an accumulation of downstream NER factors,
indicating the involvement of CSB in the response to oxidative
DNA lesions independent of the downstream NER reaction.
Importantly, CSB binding to oxidative damage was reduced
upon transcription inhibition which suggests a role of CSB in
transcription-associated repair of oxidative lesions. In CS pa-
tients, the accumulation of unrepaired oxidative DNA damage
and the subsequent prolonged transcription arrest at these le-
sions could result in apoptosis and consequentially tissue de-
generation. Since active metabolism during development and a
high level of oxidative metabolism in neural tissues may gen-
erate a considerable amount of oxidative damage, the conse-
quences of the transcription arrest are mainly disclosed by
developmental and neurological symptoms which are a hall-
mark of CS (Hoeijmakers 2007). This model is further sup-
ported by transcriptomic analysis of CSB-deficient mice which
revealed systematic suppression of growth and oxidative me-
tabolism, an altered glycolysis and an upregulated antioxidant
defense, collectively referred to as survival response (van der
Pluijm et al. 2007). Moreover, Pascucci et al. (2012) recently
observed a disturbed redox balance in patient-derived CS cells.
They showed increased intracellular ROS levels and oxidative
DNA damage. In addition, alterations in cellular metabolism
including the glycolysis pathway and oxidative metabolism
were observed. Addition of antioxidants to the cells reduced
ROS levels and at least partially reverted the alterations in
cellular metabolism, suggesting that oxidative stress plays a
causative role in CS pathology. Although there is compelling
evidence supporting this hypothesis, no direct proof is currently
present and it needs further exploration.
Within a third model, a role for the CS proteins in repair of
oxidative DNA damage specifically in mitochondrial DNA
(mtDNA) has been reported (Osenbroch et al. 2009;
Kamenisch et al. 2010; Scheibye-Knudsen et al. 2012). Mito-
chondria possess an independent repair machinery for oxida-
tive lesions, which is thought to play a crucial role in protecting
the integrity of mtDNA from the relatively high levels of ROS
generated in this organelle. Certain clinical symptoms associ-
ated with mitochondrial dysfunction are also observed in CS
patients, including the severe neurological and premature ag-
ing features (Stevnsner et al. 2002). This would suggest that
the cause of these symptoms in CS results in part from the loss
of mitochondrial function as a consequence of unrepaired
oxidative mtDNA damage due to mutations in the CS proteins.
Fig. 1 Model for resolving transcription-blocking lesions. i During
transcription, UVSSA, USP7, and CSB interact transiently with elon-
gating RNA Pol II. ii Upon encountering a lesion (indicated by star),
stalled RNA Pol II stabilizes its binding with these proteins and triggers
the recruitment of several other DNA repair factors, including CSA.
Since RNA Pol II shields the DNA lesion in its active pocket, the stalled
transcription complex must be remodeled to enable access of repair
proteins to the lesion. In the case of helix-distorting lesions (iiia), TC-
NER is initiated for which extensive modulation of stalled RNA Pol II is
needed, causing a prolonged transcriptional arrest. During this slow
process, CSB assembles a functional TC-NER complex and assists in
the remodeling of RNA Pol II. In response to DNA damage, CSB is
ubiquitinated and eventually degraded. In order to allow sufficient time
for CSB to perform its function in TC-NER, its presence is protected by
the concerted action of UVSSA and USP7 by counteracting the
ubiquitination-dependent degradation. When the required remodeling
of stalled RNA Pol II is completed, the TC-NER complex is
destabilized and CSB is degraded by the proteasome. XPA, RPA, and
the TFIIH complex are subsequently recruited. Following further helix
unwinding and lesion verification, XPG and XPF are required for the
double incision of the damaged DNA strand. The repair reaction is
completed with DNA polymerase gap filling of the repair patch and
sealing of the nicks. Oxidative lesions (iiib) have a minor effect on the
DNA helix structure, which therefore requires relatively little remodel-
ing of RNA Pol II for efficient repair. Consequently, RNA Pol II is only
slowed down or transiently arrested in response to these lesions
resulting in a faster response as compared to iiia. CSB remodeling helps
to efficiently remove oxidative lesions likely via the BER pathway or to
pass stalled complexes over the lesion (lesion bypass). However, due to
the faster response, protection of CSB from ubiquitination-dependent
degradation by UVSSA/USP7 is not necessary. After repair is complet-
ed (iv), transcription is resumed (v)
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The abovementioned hypotheses to explain the severe phe-
notypical consequences of CS do not uphold, however, for the
intriguing case of two unrelated patients with null mutations in
CSB associated with mild UVSS symptoms (Miyauchi-Hashi-
moto et al. 1998; Horibata et al. 2004). In contrast, two other
patients with a deletion of the promoter sequence of CSB
(resulting in no detectable CSB protein) have been found,
which showed the most severe CS symptoms (Laugel et al.
2008). Thus, the absence of CSB alone cannot explain the
striking variability in phenotype between CS and UVSS. A
factor possibly involved in this variability might be the expres-
sion of an evolutionary conserved CSB-PGBD3 fusion protein,
containing exons 1–5 of CSB joined in frame with the
PiggyBac transposase. Reports have indicated that this fusion
protein might play a role in the CS phenotype (Bailey et al.
2012).
The UVSSA factor
Recently, three laboratories identified UVSSA as the causative
gene for the UVsS-A complementation group. Microcell-
mediated chromosome transfer (Zhang et al. 2012), whole-
exome sequencing (Nakazawa et al. 2012), and quantitative
proteomics (Schwertman et al. 2012) were used to identify
KIAA1530 as a new TC-NER factor, which was subsequently
renamed UVSSA. Sequencing of this gene in five UVSS-A
patient cell lines revealed three different inactivating muta-
tions in the UVSSA gene (Table 1).
Within UVSSA, two conserved, though poorly character-
ized, domains are identified with homology to the Vps27-
Hrs-STAM (VHS) domain and the DUF2043 domain.
UVSS-A cells expressing UVSSA mutants without either
of these domains fail to complement UVSS-A deficiency
(Nakazawa et al. 2012), indicating that both domains are
important for TC-NER activity. The UVSSA protein was
shown to interact with the TC-NER factors RNA Pol II,
CSA, CSB, and TFIIH (Schwertman et al. 2012; Nakazawa
et al. 2012; Zhang et al. 2012). A specialized chromatin
immunoprecipitation (ChIP) procedure showed that UVSSA
resides in active, chromatin-bound TC-NER complexes up-
on UV damage. Furthermore, GFP-tagged UVSSA accumu-
lated at local UV damage in living cells with similar recruit-
ment kinetics as the TC-NER factor CSB (Schwertman et al.
2012). Together, these results showed that UVSSA is a novel
TC-NER factor.
UVSSA recruitment
There are two, though not mutually exclusive, models explaining
how UVSSA is recruited to UV lesions: (1) as an RNA Pol II
interaction partner (Schwertman et al. 2012) and (2) as a CSA
interaction partner (Zhang et al. 2012; Fei and Chen 2012).
We (Schwertman et al. 2012) observed a UV-independent
interaction between RNA Pol II and UVSSA in ChIP experi-
ments. This interaction was also observed in CSB-deficient
patient cells, indicative of a CSB-independent binding of
UVSSA to TC-NER complexes. In line with this, a CSA-
and CSB-independent accumulation of GFP-UVSSA was ob-
served at sites of local UV damage using live cell imaging. In
contrast, Zhang et al. (2012) observed UV dependency for the
UVSSA–RNAPol II interaction and showed a CSA-dependent
interaction with UVSSA in the chromatin fraction using non-
cross-linking IPs; the latter was also observed by Fei and Chen
(2012). An explanation for this apparent discrepancy in
UVSSA recruitment could be that the CS proteins may be
required for stable integration into a functional TC-NER com-
plex rather than for the recruitment of UVSSA. Transient or
low-affinity interactions could appear CSA/CSB independent
if interactions are fixed by cross-linking as in ChIP experiments
Table 1 Overview of UVSS mutations in CSA, CSB, and UVSSA
Patient/cell line Gene affected Mutation References
KPS2 UVSSA p.Lys123* 1, 3, 4, 5
KPS3 UVSSA p.Lys123* 1, 2, 3, 4, 5
UVS24TA UVSSA p.Ile31Phefs*9 1, 2, 6
XP24KO UVSSA p.Lys123* 1, 2, 7, 8
XP70TO UVSSA p.Cys32Arg 1, 7, 9
UVSS1VI CSA p.Trp361Cys 10
UVS1KO CSB p.Arg77* 3, 4, 6, 11, 12
CS3AM CSB p.Arg77* 13
References: 1. Nakazawa et al. (2012), 2. Zhang et al. (2012), 3. Itoh et al.
(1996), 4. Itoh et al. (1995), 5. Itoh et al. (1994), 6. Cleaver and Thomas
(1993), 7. Itoh et al. (2000), 8. Fujiwara et al. (1985), 9. Kawada et al.
(1986), 10. Nardo et al. (2009), 11. Horibata et al. (2004), 12. Fujiwara
et al. (1981), 13. Miyauchi-Hashimoto et al. (1998)
Fig. 2 Involvement of CSA, CSB, and UVSSA in transcription, BER,
and TC-NER. While the CS proteins have functions outside of TC-NER,
a role for UVSSA in these other processes has presently not been shown
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(Schwertman et al. 2012) and CSA/CSB dependent as ob-
served in non-cross-linking IPs (Zhang et al. 2012; Fei and
Chen 2012).
The observed CSA-dependent stable association of
UVSSA into TC-NER complexes provides the basis for a
possible molecular explanation of the UVSS/CS phenotypic
difference. The CSA protein is a subunit of an E3 ubiquitin
ligase complex (Groisman et al. 2003) that is recruited to the
site of damage by CSB (Fousteri et al. 2006). Although
essential for TC-NER, the precise role of CSA remains
largely unknown. Nardo et al. (2009) described a patient
with a specific missense CSA mutation, which causes the
mild UV-sensitive phenotype in the absence of the severe
premature aging features common in CS. Cells of this UVSS
patient were hypersensitive to UV light, but not to oxidative
damaging agents. This finding thus implies a separable role
for CSA in response to UV and oxidative DNA damage.
Interestingly, Fei and Chen (2012) showed that this same
CSA mutant disrupts the interaction of CSA with UVSSA.
This might suggest that an impaired interaction of UVSSA
with mutated CSA at sites of DNA damage results in UVSS
in this patient, while an unaffected role of CSA in other
processes—such as in oxidative DNA damage repair—pre-
vents the additional CS symptoms.
UVSSA function: a role in CSB stability
In addition to its interaction with CSA and RNA Pol II,
UVSSA forms a UV-independent protein complex with the
deubiquitinating enzyme (DUB) ubiquitin-specific protease 7
(USP7). USP7 (also known as HAUSP) has multiple roles in
the DNA damage response, as illustrated by the wide variety of
substrates including Mdm2, p53, claspin, Chfr, and histone
H2B (Li et al. 2002; Meulmeester et al. 2005; Faustrup et al.
2009; Khoronenkova et al. 2011; Khoronenkova et al. 2012).
Additionally, its diverse activity also includes targeting tumor
suppressors, immune responders, viral proteins, and epigenetic
modulators (Nicholson and Suresh Kumar 2011). Through its
interaction with UVSSA, USP7 is recruited to active TC-NER
complexes upon UV damage (Schwertman et al. 2012). Deple-
tion of USP7 leads to a similar TC-NER deficiency as seen
with UVSSA depletion, such as a decrease in UV survival and
RNA synthesis recovery after UV (Schwertman et al. 2012;
Zhang et al. 2012). From previous studies, it is known that CSB
is ubiquitinated and degraded by the proteasome in response to
UV (Groisman et al. 2006; Wei et al. 2011). In the absence of
either UVSSA or USP7, the degradation of CSB by the 26S
proteasome is faster upon UV damage. It is therefore suggested
that UVSSA stabilizes CSB after UV by targeting the pleiotro-
pic DUB USP7 to TC-NER complexes, which subsequently
removes UV-induced ubiquitin chains. The purpose of this
could be to provide an increased time frame for CSB to
orchestrate TC-NER complex formation or to efficiently com-
plete repair before CSB is degraded.
The stabilizing function of UVSSA/USP7 on CSBmight be
restricted to UV-induced TC-NER, since the reduced CSB
levels in UVSS-A cells do not result in developmental and
neurological symptoms in UVSS patients. Interestingly,
overexpression of CSB in UVSS-A cells did not correct the
TC-NER defect (Schwertman et al. 2012). This implies that the
reduced level of CSB in UVSS-A cells alone is not sufficient to
explain the UVSS phenotype. Therefore, the ubiquitination
state of CSB itself might have an additional function for proper
TC-NER, for example to mediate a ubiquitin-mediated func-
tional change in CSB, or UVSSA/USP7 might have additional
substrates that can cause the UVSS phenotype.
UVSSA function: a role in the processing of stalled RNA
Pol II
Several transcription-associated factors recognize the C-
terminal domain (CTD) of RNA Pol II by means of a con-
served CTD-interacting domain (CID). The CID fold closely
resembles that of VHS domains (Misra et al. 2002; Meinhart
and Cramer 2004), suggesting that the observed interaction
between UVSSA and RNA Pol II is mediated via the VHS
domain of UVSSA. This interaction might be important for
an additional function of UVSSA, as Nakazawa et al. (2012)
showed that UVSSA is needed for processing stalled RNA
Pol II at sites of UV damage. During TC-NER, elongating
RNA Pol II can be recycled for a new round of transcription
by means of dephosphorylating the elongating form of RNA
Pol II into the hypophosphorylated initiating form (Rockx
et al. 2000). Without the UVSSA protein, this dephosphory-
lation step is substantially inhibited (Nakazawa et al. 2012), as
previously found in CS patient cells (Rockx et al. 2000),
leading to impaired resumption of transcription initiation.
Next to its possible involvement in RNA Pol II binding, the
VHS domain has also been implicated in ubiquitin binding
(Mizuno et al. 2003), raising the possibility that UVSSA binds
ubiquitinated TC-NER proteins. Upon UV irradiation, RNA
Pol II is ubiquitinated and, under specific conditions, degraded
(Bregman et al. 1996; Anindya et al. 2007; Malik et al.
2008). Nakazawa et al. (2012) identified a UVSSA-dependent
ubiquitination of RNA Pol II, which however is not subject to
proteasomal degradation. Interestingly, this new ubiquitinated
form of stalled elongating RNA Pol II is UV specific, as it was
not observed for oxidative DNA damage induced by hydrogen
peroxide. Interaction of UVSSAwith ubiquitinated RNA Pol II
was indeed observed by Nakazawa et al. (2012). Additionally,
we (Schwertman et al. 2012) identified UVSSA in a stable
isotope labeling with amino acids in cell culture (SILAC)-based
proteomic screen for differentially ubiquitinated proteins fol-
lowing UV irradiation. While the ubiquitination status of
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UVSSA was not changed after UV, a similar SILAC ratio for
UVSSA and RNA Pol II was observed. This would suggest that
UVSSAwas co-purified by virtue of the enhanced ubiquitination
of RNA Pol II in response to UV. However, whether this inter-
action is ubiquitination dependent remains unclear.
The VHS domain of UVSSA is suggested to be also
involved in the interaction between UVSSA and CSB, since
a UVSS-A patient missense mutation (Cys32Arg) within the
VHS domain disrupts the interaction with CSB in response to
UV. Interestingly, UVSS-A cells expressing UVSSAwith this
mutation were able to restore CSB stability to wild-type levels
upon UV, while RNA Pol II ubiquitination and dephosphory-
lation remained absent (Nakazawa et al. 2012). This might
indicate that while the VHS domain of UVSSA is dispensable
for CSB stabilization, it is important for RNA Pol II processing.
Apparently, the action of UVSSA on both CSB and RNA Pol II
contributes to the UVSS phenotype. Although the precise
involvement of UVSSA in processing these RNA Pol II mod-
ifications remains to be elucidated, it is hypothesized that the
modifications themselves contribute to the coordination of the
removal of stalled RNA Pol II and formation of the TC-NER
complex and the subsequent resumption of transcription.
New insights in transcription-coupled DNA repair
from a UVSSA perspective
Mutations inUVSSAwere recently identified to cause UVSS,
a previously unresolved TC-NER deficiency disorder with
rather mild clinical manifestations as compared to CS.
UVSSA and its interaction partner USP7 were identified as
new factors involved in TC-NER repair efficiency and cell
survival after UV damage. Additionally, UVSSA is also
important for the fate and ubiquitination state of both RNA
Fig. 3 Differential aberrant processing of stalled elongating RNA Pol
II is responsible for the differences in UVSS/CS phenotype. In wild-type
cells, lesion stalled RNA Pol II initiates TC-NER to remove the tran-
scription-blocking damage. In the infrequent cases that repair cannot
take place, RNA Pol II is ubiquitinated and degraded by the proteasome
to make the lesion accessible for alternative DNA repair. In UVSS-A
cells, TC-NER does not take place. Since the prolonged stalled RNA
Pol II can still be ubiquitinated in a CSA/CSB dependent way, RNA Pol
II is degraded and the lesion is made accessible for alternative DNA
repair. In CS cells, TC-NER is blocked as well. In addition, the
ubiquitination and degradation of RNA Pol II does not take place.
The resultant persistent transcription arrest is more harmful for the cell,
since it leads to apoptosis or senescence and might contribute to the
more severe phenotype in CS patients
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Pol II and CSB. The identification of these new transcription-
coupled DNA repair factors presents us with the opportunity to
gain more insight into the molecular mechanisms underlying
the clinical differences between UVSS and CS.
The transcription defect model discussed previously is
based on a role for the CS proteins in transcription, while
assuming UVSSA is not involved in this process. The UV-
independent transient interaction between UVSSA and RNA
Pol II may suggest a role for UVSSA in transcription. However,
no other data are currently available to conclude whether
UVSSA is as equally important as CSB for transcription on
undamaged DNA. Therefore, further studies are needed to
determine the possible involvement of UVSSA in transcription.
One of the models including UVSSA involves the aberrant
processing of elongating RNA Pol II when stalled at a lesion
(Fig. 3). For efficient repair to take place, the RNA Pol II
complexmust be remodeled since it will likely shield theDNA
lesion and consequently prevent accessibility of repair proteins
(Donahue et al. 1994; Tornaletti et al. 2001; Brueckner et al.
2007; Fousteri and Mullenders 2008; Wilson et al. 2013). Ad-
ditionally,whena lesion cannotbe repaired orbypassed, stalled
RNAPol II is thought tobe ubiquitinated and degraded in order
to prevent persistent transcriptional arrest (Wilson et al. 2013).
In the absence of UVSSA, stalled RNA Pol II can still be
ubiquitinated in a CSA/CSB-dependent way, which results in
proteasomaldegradation. Incontrast, stalledRNAPol II cannot
be degraded by the proteasome in CS cells (Hanawalt and
Spivak 2008). This would suggest that the lack of DNA repair
combinedwithpersistent arrestofRNAPol IIatDNAlesions in
CS cells, which results in apoptosis or senescence, might be
causative for the severe CS phenotype. In UVSS-A cells,
prolonged arrest is prevented and the lesion is made accessible
for alternativeDNArepair bydegradationofRNAPol II, hence
resulting in themilderUVSS phenotype (Fig. 3).
The CS proteins play important roles in both TC-NER and
oxidative DNA damage repair, while the precise function of
UVSSA in these processes remains unclear. The previously
discussed oxidative damage model assumes that UVSSA does
not play a role in oxidative DNA damage repair (Spivak and
Hanawalt 2006), hence explaining the milder phenotype of
UVSS. We would like to postulate a model including UVSSA
and its role in both repair pathways (Fig. 1). We hypothesize
that based on the nature of the DNA damage, distinct modula-
tions of lesion stalled RNA Pol II are required and that this
involves a remodeling function of CSB. While oxidative le-
sions only slow down or transiently arrest RNA Pol II, more
helix-distorting lesions (such as those induced by UV) would
lead to a prolonged transcriptional arrest. In the case of transient
transcription arrest, CSB remodeling assists in the efficient
removal of a lesion or in bypassing the lesion (Doetsch 2002;
Charlet-Berguerand et al. 2006; Damsma and Cramer 2009). In
contrast, for a prolonged blocked transcription, more time
would be required for CSB to assemble a functional TC-NER
complex and to assist in remodeling of the stalled RNA Pol II.
The presence of CSB should, in the latter case, be protected by
the concerted action of UVSSA/USP7 to allow sufficient time
for CSB to perform its remodeling function. Whether the
ubiquitination of CSB takes place at all after transient transcrip-
tion arrest at oxidative DNA lesions or if CSB is ubiquitinated
but not degraded before the repair of these lesions is completed
remains to be elucidated. In this proposed model, mutations in
UVSSAwould lead to dysfunctional TC-NER only, since the
lack of CSB protection would not affect repair or restart of
transcription blocked by oxidative lesions.
The discovery of UVSSA enables us to test the proposed
models in greater detail and whether or not they are mutually
exclusive. To further substantiate the hypothesis that the
phenotypical difference between UVSS and CS is derived
from different sensitivities for endogenous levels of oxida-
tive DNA damage, dedicated lesion-specific DNA repair
assays are required (Spivak et al. 2009). Furthermore,
dissecting the differences in molecular composition between
repair complexes stalled at UV-induced lesions or oxidative
lesions will help us to better understand the molecular mech-
anism of transcription-coupled repair for different types of
DNA damage. Characterization of repair complexes present
on the different lesions using immunoprecipitation combined
with mass spectrometry would be a powerful tool to study
this. Another interesting area for further investigation is the
differential ubiquitination of several DNA repair factors,
which is likely an important driver of protein hand over
and passing of repair intermediates through successive steps
during TC-NER. Especially the actual and/or precise in-
volvement of USP7 in changing the ubiquitination state of
CSB and RNA Pol II upon UV is of great interest, as is the
establishment of identified or new E3 ubiquitin ligases re-
sponsible for the ubiquitin modifications. Finally, with the
identification of UVSSA, a UVSS-A mouse model can now
be generated for a more extensive study of the UVSS phe-
notype and molecular defect. Also, an overall comparison of
the UVSS-A mouse with the already existing CS mouse
models in an isogenic background will be a valuable source
of information. Phenotypic consequences and possible dif-
ferential responses to various genotoxic agents in the whole
organism will contribute to our understanding of the clinical
differences of CS versus UVSS on a molecular level.
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